# US 2010/0166852 A1 · Cream gels comprising at least one retinoid and benzoyl peroxide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166852 A1
- Document ID: US20100166852A1
- Status: Published application
- Kind: A1
- Application number: 12/457,788
- Filed: 2009-06-22
- Published: 2010-07-01
- Earliest claimed: 2006-12-21
- Assignees: Galderma Research & Development
- Inventors: Claire Mallard; Fabienne Louis; Emmanuelle At
- Web page: https://patentgrep.com/patent/US20100166852A1

## CPC

- A61K 8/04: Dispersions; Emulsions
- A61K 8/11: Encapsulated compositions
- A61K 8/38: Percompounds, e.g. peracids
- A61K 8/671: {Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal}
- A61K 8/73: Polysaccharides
- A61K 8/731: {Cellulose; Quaternized cellulose derivatives}
- A61K 8/8152: {Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers}
- A61K 8/8158: {Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/203: Retinoic acids {; Salts thereof}
- A61K 31/327: Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/08: Antiseborrheics
- A61P 17/10: Anti-acne agents
- A61P 17/12: Keratolytics, e.g. wart or anti-corn preparations
- A61P 17/14: for baldness or alopecia
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61Q 5/00: Preparations for care of the hair
- A61Q 5/008: {Preparations for oily hair}
- A61Q 7/00: Preparations for affecting hair growth
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/008: {Preparations for oily skin}
- A61Q 19/08: Anti-ageing preparations
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61K 2800/30: Characterized by the absence of a particular group of ingredients
- A61K 2800/592: Mixtures of compounds complementing their respective functions
- A61K 2800/80: Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K 2800/805: Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention relates to a composition in the form of a cream gel comprising, in a physiologically acceptable medium, at least one dispersed retinoid and dispersed benzoyl peroxide, to its process of preparation and to its use in cosmetics and in dermatology.

## Claims

### Claim 1

A topically applicable, physically, chemically and rheologically stable cream gel dermatological composition useful for the prevention or treatment of dermatological conditions linked to disorders of cell differentiation and/or proliferation and/or of keratinization, comprising a homogeneous dispersion of a fatty phase in an aqueous phase, including at least one dispersed retinoid and dispersed benzoyl peroxide, at least one lipophilic compound and at least one gelling agent, formulated into a topically applicable, physiologically acceptable medium therefor.

### Claim 2 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising from 0.0001% to 20% of said at least one retinoid.

### Claim 3 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising from 0.0001% to 20% of benzoyl peroxide.

### Claim 4 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said benzoyl peroxide being encapsulated.

### Claim 5 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said benzoyl peroxide being in free form.

### Claim 6 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising at least one pH-independent gelling agent.

### Claim 7 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising at least one wetting agent.

### Claim 8 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising at least one chelating agent.

### Claim 9 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, devoid of any emulsifying agent.

### Claim 10 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said at least one retinoid comprising adapalene.

### Claim 11 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said at least one retinoid comprising retinoic acid, tretinoin and/or tazarotene.

### Claim 12 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said at least one retinoid comprising at least one compound selected from the group consisting of:
6-(3-methylphenyl)-2-naphthoic acid and its methyl ester,
6-(4-(tert-butyl)phenyl)-2-naphthoic acid and its methyl ester,
6-(3-(tert-butyl)phenyl)-2-naphthoic acid and its methyl ester,
6-(3,4-dimethoxyphenyl)-2-naphthoic acid and its methyl ester,
6-(p-(1-adamantylthio)phenyl)-2-naphthoic acid and its methyl ester,
6-(3-(1-adamantyl)-4-methoxyphenyl)-2-naphthoic acid (adapalene) and its methyl ester,
the methyl ester of 6-[3-(1-adamantyl)-4-(tert-butyldimethylsilyloxy)phenyl]-2-naphthoic acid,
the methyl ester of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthoic acid,
6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthoic acid,
the methyl ester of 6-[3-(1-adamantyl)-4-decyloxyphenyl]-2-naphthoic acid,
6-[3-(1-adamantyl)-4-decyloxyphenyl]-2-naphthoic acid,
the methyl ester of 6-[3-(1-adamantyl)-4-hexyloxyphenyl]-2-naphthoic acid,
6-[3-(1-adamantyl)-4-hexyloxyphenyl]-2-naphthoic acid,
the methyl ester of 6-[3-(1-adamantyl)-4-methoxyphenyl]-4-acetoxy-1-methyl-2-naphthoic acid,
6-[3-(1-adamantyl)-4-methoxyphenyl]-4-hydroxy-1-methyl-2-naphthoic acid,
the methyl ester of 6-[3-(1-adamantyl)-4-methoxyphenyl]-4-hydroxy-1-methyl-2-naphthoic acid,
the methyl ester of 6-[3-(1-adamantyl)-4-methoxyphenyl]-1-methyl-2-naphthoic acid,
6-[3-(1-adamantyl)-4-methoxyphenyl]-1-methyl-2-naphthoic acid,
6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthalenemethanol,
the ethyl amide of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid,
the morpholide of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid,
the methyl ester of 6-[3-(tert-butyl)-4-methoxyphenyl]-2-naphthoic acid,
6-[3-(tert-butyl)-4-methoxyphenyl]-2-naphthoic acid,
the methyl ester of 6-[3-(1,1-dimethyldecyl)-4-methoxyphenyl]-2-naphthoic acid,
6-[3-(1,1-dimethyldecyl)-4-methoxyphenyl]-2-naphthoic acid.

### Claim 13 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said at least one lipophilic compound being selected from the group consisting of vegetable, mineral, animal and synthetic oils, silicone oils and mixtures thereof.

### Claim 14 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said at least one lipophilic compound being selected from the group consisting of liquid paraffins, sweet almond oil, palm oil, soybean oil, sesame oil, sunflower oil, lanolin, squalene, fish oil, mink oil, squalane, cetearyl isononanoate, isopropyl palmitate, diisopropyl adipate, caprylic/capric triglyceride, a volatile or non-volatile silicone oil and natural or synthetic waxes.

### Claim 15 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising from 0.001% to 15% of said at least one gelling agent.

### Claim 16 (depends on 15)

The stable cream gel dermatological composition as defined by claim 15, said at least one gelling agent being selected from the group consisting of the family of polyacrylamides; “electrolyte-insensitive” carbomers; polysaccharides; cellulose and derivatives thereof; and magnesium aluminum silicates.

### Claim 17 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, said at least one gelling agent being selected from the group consisting of sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80 mixture, the polyacrylamide/C13-14 isoparaffin/laureth-7 mixture, Carbopol 1382, xanthan gum, hydroxypropylmethylcellulose and hydroxyethylcellulose.

### Claim 18 (depends on 7)

The stable cream gel dermatological composition as defined by claim 7, said at least one wetting agent comprising a poloxamer and/or propylene glycol.

### Claim 19 (depends on 10)

The stable cream gel dermatological composition as defined by claim 10, comprising 0.1% adapalene and 2.5% benzoyl peroxide.

### Claim 20 (depends on 10)

The stable cream gel dermatological composition as defined by claim 10, comprising 0.3% adapalene and 1% benzoyl peroxide.

### Claim 21 (depends on 10)

The stable cream gel dermatological composition as defined by claim 10, comprising 0.10% adapalene and 0.25% benzoyl peroxide.

### Claim 22 (depends on 10)

The stable cream gel dermatological composition as defined by claim 10, comprising a fluid cream gel.

### Claim 23 (depends on 10)

The stable cream gel dermatological composition as defined by claim 10, comprising a thick cream gel.

### Claim 24 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, having a semiliquid consistency.

### Claim 25 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, having a solid consistency.

### Claim 26 (depends on 1)

The stable cream gel dermatological composition as defined by claim 1, comprising:
from 0.001% to 5% of at least one retinoid;
from 0.025% to 10% of benzoyl peroxide;
from 30% to 95% of water;
from 0.01% to 15% of one or more gelling agents and/or suspending agents and/or pH-independent gelling agents;
from 2% to 50% of fatty phase;
optionally, up to 1.5% of chelating agents;
optionally, up to 10% of one or more wetting agents;
optionally, up to 3% of preservatives;
optionally, up to 20% of humectants and/or emollients;
optionally, up to 3% of stabilizing agents; and
optionally, up to 10% of neutralizing agents.

### Claim 27 (depends on 1)

A process for the formulation of the cream gel composition as defined claim 1, successively comprising the following stages:
a) mixing at least one retinoid with water until it is completely dispersed, to obtain active phase 1;
b) mixing the benzoyl peroxide with water until it has completely dispersed, to obtain active phase 2;
c) mixing at least one gelling agent and/or suspending agent and/or pH-independent gelling agent with water, optionally one or more chelating agents, one or more preservatives, one or more humectants and/or emollients, one or more stabilizing agents and the hydrophilic additives, to obtain the aqueous phase;
d) optionally, mixing at least two lipophilic compounds, to obtain the fatty phase;
e) mixing the 2 active phases obtained in a) and b), to obtain a single active phase;
f) introducing the single active phase obtained in e) into the aqueous phase obtained in c);
g) introducing the lipophilic compound or optionally the fatty phase obtained in d), to obtain a cream gel;
h) if necessary, adding heat-sensitive additives;
i) if necessary, introducing a neutralizing agent for the gelling agent into the cream gel obtained in g) or h);
j) if necessary, adding further water.

### Claim 28 (depends on 1)

A regime or regimen for the prevention or treatment of a dermatological condition linked to a disorder of cell differentiation and/or proliferation and/or of keratinization, comprising topically applying onto the skin of an individual in need of such treatment, a thus effective amount of the stable cream gel dermatological composition as defined by claim 1.

### Claim 29 (depends on 1)

A regimen or regimen for the prevention or treatment of acne vulgaris, comprising topically applying onto the skin of an individual in need of such treatment, a thus effective amount of the stable cream gel dermatological composition as defined by claim 1.

### Claim 30 (depends on 1)

A regime or regimen for the treatment of skin with a tendency towards acne, for causing hair growth or preventing hair loss, for combating the greasy appearance of the skin or hair, for protecting against the harmful effects of the sun or for preventing and/or combating photoinduced or chronologic aging, comprising topically applying onto the skin of an individual in need of such treatment, a thus effective amount of the stable cream gel dermatological composition as defined by claim 1.
